| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/30/1997 | US5672477 Streptococcus lactis plasmid encoding for mucoidness |
| 09/30/1997 | US5672473 Methods of identifying compounds useful for treating autoimmune diseases |
| 09/30/1997 | US5672471 Assay for detection and/or quantifying a mammalian IgA antibody response to Epstein-Barr virus membrane antigen using EBV-MA gp 350/220 lacking the transmembrane anchor domain |
| 09/30/1997 | US5672372 Method for sweetening a food composition with single-chain monellin analogs |
| 09/30/1997 | US5672350 Administering to elicit immune response which reduces severity of bovine coronavirus infection in mammal |
| 09/30/1997 | US5672349 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use |
| 09/30/1997 | US5672347 Administering in therapeutically effective dosage to suppress transplantation immunity |
| 09/30/1997 | US5672345 Stable genetic engineered vaccines |
| 09/30/1997 | US5672343 N- 3 deletion mutants of the long form of CSF-1 |
| 09/30/1997 | US5672336 Process of preparing microparticulate collagen, collagen-based products thereby and method of applying same |
| 09/30/1997 | US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected |
| 09/25/1997 | WO1997035197A1 PURIFICATION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
| 09/25/1997 | WO1997035196A1 Engineering affinity ligands for macromolecules |
| 09/25/1997 | WO1997035194A2 Enantiomeric screening process, and compositions therefor |
| 09/25/1997 | WO1997035193A1 Cryptic peptides and method for their identification |
| 09/25/1997 | WO1997035028A1 Cytostatin iii |
| 09/25/1997 | WO1997035027A1 Chemokine alpha 3 |
| 09/25/1997 | WO1997035023A2 Alteration of amino acid compositions in seeds |
| 09/25/1997 | WO1997035022A1 Export systems for recombinant proteins |
| 09/25/1997 | WO1997035021A2 Prostate specific antigen oligo-epitope peptide |
| 09/25/1997 | WO1997035012A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | WO1997035011A1 Recombinant process for the production in pseudomonas putida of the cytochrome c551 of pseudomonas aeruginosa |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997035009A1 Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 09/25/1997 | WO1997035008A1 Methods and compositions of chimeric polypeptides for tumor antigen vaccines |
| 09/25/1997 | WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | WO1997035006A1 Human cell death-associated protein |
| 09/25/1997 | WO1997035005A2 Cftr gene regulator |
| 09/25/1997 | WO1997035004A1 Cell stimulation |
| 09/25/1997 | WO1997035001A1 Fungal gene encoding resistance to the phytotoxin cercosporin |
| 09/25/1997 | WO1997034998A1 Human cytokine polypeptide |
| 09/25/1997 | WO1997034997A1 Human endometrial specific steroid-binding factor i, ii and iii |
| 09/25/1997 | WO1997034996A2 Induction quiescence in bacterial cells and uses thereof |
| 09/25/1997 | WO1997034930A1 Stable factor viii/ von willebrand factor complex |
| 09/25/1997 | WO1997034929A1 Process for extraction of a growth factor complex |
| 09/25/1997 | WO1997034928A1 Method for assessing risk to develop psychotic disease |
| 09/25/1997 | WO1997034927A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/25/1997 | WO1997034926A2 Bacillus thuringiensis genes encoding nematode-active toxins |
| 09/25/1997 | WO1997034925A1 Conotoxin peptide pviia |
| 09/25/1997 | WO1997034921A1 Conjugated mucin peptide vaccines |
| 09/25/1997 | WO1997034920A1 Assays for kdr/flk-1 receptor tyrosine kinase inhibitors |
| 09/25/1997 | WO1997034914A1 Compositions for the diagnosis and treatment of chediak-higashi syndrome |
| 09/25/1997 | WO1997034913A1 Mycoplasma arthritidis superantigen |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034642A1 Method for removing unconventional transmissible agents from a protein solution |
| 09/25/1997 | WO1997034641A1 Stat6 deficient transgenic animals |
| 09/25/1997 | WO1997034634A1 Single chain fv constructs of anti-ganglioside gd2 antibodies |
| 09/25/1997 | WO1997034633A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/25/1997 | WO1997034630A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 09/25/1997 | WO1997034629A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | WO1997034628A1 Milk of transgenic animals containing human alpha1-antitrypsin and use of human alpha1-antitrypsin to treat bile acid related diseases |
| 09/25/1997 | WO1997034626A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034625A1 Cystatin b mutants |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997034620A1 Peptide inhibitors of neurotransmitter secretion by neuronal cells |
| 09/25/1997 | WO1997034618A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034617A1 Hla binding peptides and their uses |
| 09/25/1997 | WO1997034613A1 Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 09/25/1997 | WO1997034473A1 Craf1 (traf-3) isoforms and uses thereof |
| 09/25/1997 | WO1997031116A3 Recombinant ribonuclease proteins |
| 09/25/1997 | WO1997031112A3 Compounds and related methods for modulating potassium ion channels and assays for such compounds |
| 09/25/1997 | WO1997030082A3 Antifungic and antibacterial peptide |
| 09/25/1997 | WO1997030024A3 Lipids and their use, for example, in liposomes |
| 09/25/1997 | WO1997027220A3 Substrates and inhibitors for cysteine protease ich-1 |
| 09/25/1997 | WO1997026277A3 Morphogen analogs and methods for producing them |
| 09/25/1997 | WO1997022363A3 Improved pharmaceutical compositions |
| 09/25/1997 | WO1997020048A3 Modified SFV molecules which mediate adhesion between cells and uses thereof |
| 09/25/1997 | WO1997019178A3 Autoantigenic metal proteases and methods of diagnosing autoimmune diseases |
| 09/25/1997 | WO1997012043A3 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 09/25/1997 | WO1997008317A3 Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof |
| 09/25/1997 | DE19649604C1 Purification and refolding of human papilloma virus proteins extracted from cells |
| 09/25/1997 | CA2283633A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 09/25/1997 | CA2257343A1 Fungal gene encoding resistance to the phytotoxin cercosporin |
| 09/25/1997 | CA2250222A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249995A1 Chemokine alpha 3 |
| 09/25/1997 | CA2249994A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | CA2249449A1 Mycoplasma arthritidis superantigen |
| 09/25/1997 | CA2249395A1 Conjugated mucin peptide vaccines |
| 09/25/1997 | CA2249368A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | CA2249251A1 Human cytokine polypeptide |
| 09/25/1997 | CA2249179A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | CA2248868A1 Apoptosis inducing molecule ii |
| 09/25/1997 | CA2248843A1 Process for extraction of a growth factor complex |
| 09/25/1997 | CA2248754A1 Export systems for recombinant proteins |
| 09/25/1997 | CA2248659A1 Hla binding peptides and their uses |
| 09/25/1997 | CA2248614A1 Human cell death-associated protein |
| 09/25/1997 | CA2248579A1 Induction quiescence in bacterial cells and uses thereof |
| 09/25/1997 | CA2248136A1 Human endometrial specific steroid-binding factor i, ii and iii |
| 09/25/1997 | CA2247807A1 Bacillus thuringiensis genes encoding nematode-active toxins |
| 09/25/1997 | CA2242342A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/25/1997 | CA2220959A1 Alteration of amino acid compositions in seeds |
| 09/25/1997 | CA2198920A1 Pathogen-resistant plants and method for production thereof |
| 09/24/1997 | EP0796913A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins |
| 09/24/1997 | EP0796867A1 Peptide, bronchodilator and blood flow ameliorant |
| 09/24/1997 | EP0796865A2 Adsorbent and method for removing chemokines |
| 09/24/1997 | EP0796623A2 Pharmaceutical preparation for the treatment of blood coagulation disorders |
| 09/24/1997 | EP0796341A2 Identification of genes |
| 09/24/1997 | EP0796339A1 Packaging cell lines for generation of high titers of recombinant aav vectors |
| 09/24/1997 | EP0796338A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |